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Introduction
Mastocytosis is the clonal proliferation of aberrant 
mast cells into one or more organ systems. Its 
clinical presentation is heterogeneous, ranging from 
cutaneous mastocytosis (CM), defined as skin-limited 
disease, to systemic mastocytosis (SM), characterized 
by progressive mast cell infiltration of internal organs 
accompanied by mast cell degranulation symptoms, 
organomegaly, organ impairment, or loss of function. 
Although SM frequently affects the lymph nodes, 
spleen, liver, gastrointestinal tract, bones, and bone 
marrow, mast cell infiltration of the exocrine glands 
is rare [1].
Case Synopsis
A 54-year-old woman with osteoporosis and 
gastroesophageal reflux disease developed a 
persistent non-pruritic rash. Lesions emerged on the 
trunk and then spread rapidly to the bilateral upper 
and lower extremities. She subsequently developed 
dry eyes and dry mouth. On review of systems, the 
patient endorsed fatigue. Physical exam revealed 
hundreds of red-brown telangiectatic macules. 
Darier sign (urtication with stroking of the skin) 
was negative (Figure 1). There was no palpable 
hepatosplenomegaly.
Skin punch biopsy revealed superficial perivascular 
and interstitial spindle-shaped mast cells (Figure 2, 
top) highlighted by CD117 immunostain (Figure 2, 
bottom left). These findings were consistent with 
cutaneous mastocytosis (CM) – specifically TMEP. 
Cutaneous mast cells were positive for CD25 (Figure 
2, bottom right). Serum tryptase level was elevated 
at 28 ng/mL (reference range: <11.5 ng/mL).
Abstract
We present the case of woman in her 50s who 
developed numerous red-brown telangiectatic 
macules on her trunk and extremities, as well as 
persistent dry eyes and dry mouth. Skin biopsy was 
consistent with telangiectasia macularis eruptiva 
perstans (TMEP). Serum tryptase was elevated 
suggesting systemic involvement. Anti-Ro and La 
were negative. ANA was positive. Salivary gland 
biopsy revealed a focus score of 3 and immunostains 
revealed infiltrates of aberrant CD117 positive 
mast cells. This case suggests a mechanistic role of 
mastocytosis in salivary compromise.
Figure 1. Telangiectasia macularis eruptiva perstans. Patient on 
the day of presentation with 3-4mm red-brown macules on the 
thighs.
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The patient endorsed daily persistent dry eyes and 
dry mouth for a period of greater than 3 months. 
Anti-SSA (Ro) and anti-SSB (La) were negative. Anti-
nuclear antibody was positive with a titer of 1:2569. 
Rheumatoid factor and anti-double stranded DNA 
were negative. Complement C3 and C4 were within 
normal limits. Lower lip salivary gland (LSG) biopsy 
revealed a focus score of 3 (defined as a number 
of lymphocytic foci with an aggregate of ≥ 50 
lymphocytes). Immunostains of the LSG biopsy 
revealed infiltrates of abnormal appearing CD117 
positive mast cells (Figure 3).
Case Discussion
We describe an unusual case of patient with TMEP 
with evidence of indolent systemic involvement and 
a clinical sicca complex. TMEP is an unusual variant of 
CM. It is a well-established entity in the dermatologic 
literature with descriptions dating back to 1930. 
Lesions are characterized by telangiectatic macules 
on a red to brown background. Darier sign is typically 
negative. The histology of TMEP demonstrates a 
perivascular infiltrate of mast cells on skin biopsy [2]. 
TMEP is rarely associated with systemic involvement.
The World Health Organization (WHO) has established 
diagnostic criteria for SM, requiring the presence of 
one major and one minor criterion or three minor 
criteria [1]. The major criterion of multifocal dense 
mast cell infiltrates in sections of bone marrow could 
not be evaluated in our patient as she declined the 
procedure. However, the persistently elevated serum 
tryptase levels (meeting one WHO minor criterion), 
history of osteoporosis and fatigue were suggestive 
Figure 2. Skin punch biopsy specimen. Histopathology reveals a superficial perivascular and interstitial dermal spindle-cell infiltrate 
(H&E: A, 200%; B, 400%); highlighted by CD117 immunohistochemistry (C, 400%) consistent with cutaneous mastocytosis; a subset of 
mast cells was also immunoreactive for CD25 (D, 600%).
Volume 23 Number 10 | October 2017 
DOJ 23 (10): 11
- 3 - 
Dermatology Online Journal  ||  Case Presentation
of systemic involvement. In addition, skin biopsy 
revealed cutaneous mast cells positive for CD25 – a 
finding predictive of systemic mastocytosis (SM), [3]. 
Furthermore, recent studies demonstrate that adult-
onset CM is highly suggestive of SM, especially in 
the setting of elevated tryptase levels [4]. Additional 
studies show that almost all patients with adult onset 
CM, in fact have SM with cutaneous involvement [5].
We considered a diagnosis of primary Sjögren 
Syndrome (pSS) in our patient. However anti-Ro 
and anti-La were negative. Despite LSG biopsy focus 
score of 3, there was higher clinical suspicion for a 
secondary cause of the patient’s sicca symptoms. The 
aggregates of mast cells noted on LSG histopathology 
were unusual. Mast cells are typically sparse and 
sporadic in the histology of normal salivary glands 
and in pSS [6,7]. In the setting of biopsy-proven TMEP 
and elevated serum tryptase levels, this case suggests 
a mechanistic role of mastocytosis; it is plausible 
that aberrant mast cell infiltration of the salivary 
glands resulted in glandular compromise producing 
a clinical sicca complex. A similar mechanism has 
been reported only once in the literature. Bac and 
Kooy described the case of a patient presenting with 
urticaria pigmentosa, another form of cutaneous 
mastocytosis, with systemic involvement and sicca 
symptoms. Histopathologic findings on LSG biopsy 
were similar to the present case, revealing an 
abnormal mast cell infiltrate [7].
Alternatively the findings in our case may represent 
concomitant pSS and TMEP. This association has 
been reported once in the literature by Erbay et al. 
However their patient exhibited more conclusive 
evidence of pSS with positive Ro antibodies. LSG 
histology in that case revealed an increased number 
of tryptase positive mast cells similar to the findings 
we report [8]. It is thought that mast cell abnormalities 
and autoimmunity may be linked as has been well 
established in rheumatoid arthritis [9].
Conclusion
Differentiating between pSS and other potential 
etiologies of sicca symptoms is challenging and 
requires comprehensive investigation including 
clinical evaluation, laboratory studies, and 
histopathology [10]. Clinicians should pay close 
attention to any extra-glandular signs and symptoms, 
as these may guide additional diagnostic work up.
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Figure 3. Lower lip salivary gland biopsy. Minor salivary gland 
tissue demonstrating CD117 positive stromal mast cells by 
immunohistochemistry, 600%.
